+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Ages
All Genders
ID02745158

Global Fibrodysplasia Ossificans Progressiva FOP Patient Registry to Collect Health and Disease Information

Led by The International FOP Association · Updated on 2026-04-08

800

Participants Needed

1

Research Sites

282 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a global, voluntary registry to collect information about people living with Fibrodysplasia Ossificans Progressiva FOP, a rare condition. This observational study gathers data directly from patients and their caregivers through a secure online portal. The main goals are to unite the worldwide FOP community for clinical trial participation, improve understanding of the diseases natural history, and study treatment outcomes. Participants provide their information via a Patient Portal, sharing details about their demographics, diagnosis, medical care, symptoms, physical functioning, pain, and use of assistive devices. A Physician Portal is also in development to collect clinical data from doctors. The registry allows for flexible participation, with optional data fields to reduce burden. Data collection includes information on new bone growth, flare-ups, mobility, and signs related to various body systems. After consenting, participants enter their initial data and are encouraged to update it at least twice a year for up to 10 years. The study measures patient-reported changes through surveys at baseline and regular intervals. Participants can withdraw at any time without penalty. The registry has no set end date and aims to continue as long as it remains valuable to the FOP community.

CONDITIONS

Brief Title

The Fibrodysplasia Ossificans Progressiva (FOP) Registry

Research Team

M

Mark S Hamilton, PhD

S

Sammi Kile, MS

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here